Search
Close this search box.

eSudoe
2021
2027

ONCONET SUDOE

European Network for translational Research and Innovation in oncology

Axis 1: Research and innovation
OBJECTIVE 1B1 :
Strengthening the synergic and networking operation of R+i at a transnational level in the specific Sudoe sectors as from smart specialisation
STATE: Terminado
CODE: SOE1/P1/F0082
TOTAL ELIGIBLE COST (€)
2.276.288,35
AID FEDER (€)
1.707.216,27
Angela Mocca Licciardi

PROJECT MANAGER

SECTORS: Biotechnology and health (including the biomedical and pharmaceutical industry)
ANNOUNCEMENT: Primera
DURATION:
1 July, 2016
30 June, 2019
RESULTS: 0000-00-00
PRIMARY BENEFICIARY:
Université Toulouse III Paul Sabatier. Bureau Europe. (FR)
OTHER BENEFICIARIES:

2. Navarrabiomed- Fundación Miguel Servet. FR
3. Biocat, la Fundació BioRegió de Catalunya. ES
4. Fundación Centro Nacional de Investigaciones Oncológicas. Biología Computacional Estructural. ES
5. Fundación Parque Tecnológico de Ciencias de la Salud de Granada. ES
6. Universidade de Coimbra. Faculdade de Medicina. PT
7. Institut Català d'Oncologia. ES

The various types of cancer are universal chronic diseases that are nowadays one of the main causes of death. Several member states of the European Union have drawn up specific public policies regarding cancer, but these policies are not currently subject to transverse comparative studies. This is precisely the objective of the ONCONET SUDOE project: analysing and comparing in each territory of the south-west European network the public health policies as to prevention, diagnosis, therapeutic innovation, and the use of information and communication technologies in the administration of patients. This approach may give rise to the pooling of certain resources and the equalisation of professional practices.

#HumansOfSudoe